Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 2 3Phase 1 2

Status

Recruiting 2Active not recruiting 1

Sponsor Class

NIH 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 2CNS 1

Conditions

Urinary Bladder Neoplasms 2Non-Muscle Invasive Bladder Neoplasms 1Neuroblastoma 1Ganglioneuroblastoma 1

Interventions

pembrolizumab 60Carboplatin 60Paclitaxel 51Magnetic Resonance Spectroscopy 42Specimen Handling 41Cisplatin 41Gemcitabine 34Bevacizumab 31Docetaxel 30Leucovorin 27Doxorubicin 27Fluorouracil 26Dexamethasone 25Cyclophosphamide 25Pemetrexed 23Radiotherapy 22Radiation 22Oxaliplatin 22Etoposide 21durvalumab 20Nivolumab 20Vincristine 19Taxes 19Rituximab 19Irinotecan 19Prednisone 18Letrozole 18Capecitabine 17Lenalidomide 16Immunoglobulin G 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Transurethral Resection of Bladder × 30 days × Clear all
NCT06172296 2026-06-03

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

National Cancer Institute (NCI)

Phase 3 Recruiting
478 enrolled
CNS

Neuroblastoma, Ganglioneuroblastoma

NCT07000084 2026-06-02

GAIN-BCG

Alliance for Clinical Trials in Oncology

Phase 3 Recruiting
330 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT03775265 2026-05-29

Chemoradiotherapy With or Without Atezolizumab in Treating Patients With Localized Muscle Invasive Bladder Cancer

National Cancer Institute (NCI)

Phase 3 Active not recruiting
475 enrolled
Genitourinary

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡